Bone Turnover Markers (Serum CTX and P1NP) in the Sports RD Workup: Why the Paired Resorption-and-Formation Panel Catches the Active Bone-Loss Signal DXA Reads Six Months Late, the Draw-Protocol Discipline That Controls the Diurnal and Meal-State Variance the Standard Reference Ranges Ignore, and the SOAP Assessment Structure That Documents the Coupled-Uncoupled Read So the Referral Starts at the Right Question

A 22-year-old female collegiate cross-country runner arrives on referral from her sports medicine physician in week 6 of the spring build with a chief complaint of two consecutive tibial stress reactions on the same tibia across the last twelve months. The referral note reads "DXA within reference for age, please rule out low energy availability and inadequate calcium and vitamin D intake." Her most recent DXA drawn three months ago after the first stress reaction showed a lumbar spine Z-score of −0.4 and a total hip Z-score of −0.6, both flagged in the report as "within reference for age." Her intake at the sports RD visit reads clean on the surface — she is eating three meals plus two snacks, her computed energy availability across a 7-day food log paired against her Training Peaks record sits at 33 kcal/kg fat-free mass per day (just above the 30 kcal/kg threshold the LEA literature holds), her serum 25-hydroxyvitamin D drawn last month came back at 38 ng/mL, her serum calcium is 9.4 mg/dL. Her menstrual cycle has been regular across the last six months. The presenting picture reads as a marginal energy availability with two stress reactions to explain, and the DXA she just paid $250 out of pocket for reads back as "fine."

The DXA is not wrong. It is the wrong tool for the question the presenting picture is asking. DXA measures bone mineral density integrated across many months to years of prior bone-turnover history. A DXA drawn today reflects the balance of resorption and formation the athlete's skeleton has done across the last 12-to-24 months. It cannot see what her bone-turnover balance is doing this week, this month, or this training block. Two consecutive stress reactions on the same tibia inside a twelve-month window is not a "DXA within reference" answer to give her. It is the signal that the bone-remodeling coupling — the tight regulatory pairing of osteoclast-driven resorption with osteoblast-driven formation that keeps microdamage repair matched to loading — has decoupled toward net resorption, and the sports RD workup that catches that signal is the paired bone-turnover-marker panel, not the DXA.

This post is the bone-turnover-marker interpretation guide for the sports RD: what serum C-terminal telopeptide (CTX) and serum procollagen type 1 N-terminal propeptide (P1NP) actually measure and why they read a different signal from DXA, the athlete-specific draw-protocol discipline that controls the diurnal and meal-state variance the standard reference ranges quietly absorb, the four intake presentations that should trigger the paired panel regardless of the DXA read, the differential that separates the coupled high-turnover pattern of a healthy loaded skeleton from the uncoupled net-resorption pattern of early LEA-driven bone loss from the acute-training-response artifacts that shift the markers transiently, the SOAP assessment structure that documents the coupled-versus-uncoupled read so the endocrinology or sports-medicine referral starts at the correct question, and the paired energy-availability-plus-mechanical-loading intervention loop the sports RD holds across the 12-to-16-week reassessment cadence.

What CTX and P1NP Actually Measure

Serum C-terminal telopeptide of type 1 collagen (CTX, or β-CrossLaps on the Roche assay) is a fragment cleaved from mature type 1 collagen during osteoclast-mediated resorption of bone matrix. Circulating CTX concentration is the most reproducible serum marker of active bone resorption in current clinical use. It rises within hours of pharmacologic or physiologic increases in resorption and falls within weeks of resorption suppression. It has strong diurnal variation with peak concentrations in the early morning (roughly 04:00 to 08:00) and trough concentrations in the early afternoon, with the peak-to-trough amplitude commonly exceeding 50 percent of the mean. It is meaningfully suppressed by food intake (roughly 20 to 40 percent within two hours of a meal). Any reference range published on the marker assumes a fasted morning draw for those reasons, and any deviation from that draw protocol invalidates the interpretation.

Serum procollagen type 1 N-terminal propeptide (P1NP) is a cleavage fragment released when type 1 procollagen is trimmed to mature collagen during osteoblast-mediated bone formation. Circulating P1NP concentration is the most reproducible serum marker of active bone formation. It has meaningfully lower diurnal variation than CTX (typically under 15 percent peak-to-trough) and meaningfully lower meal-state sensitivity, but the reference ranges still assume the morning fasted draw for consistency across paired-panel interpretation.

Read together as a paired panel, CTX and P1NP describe the current bone-remodeling activity in two dimensions: the total volume of turnover (both markers elevated together indicates coupled high turnover, both markers suppressed together indicates coupled low turnover) and the balance between resorption and formation (CTX elevated relative to P1NP indicates uncoupled net resorption, P1NP elevated relative to CTX indicates uncoupled net formation). DXA cannot separate any of those four patterns. The paired marker panel can. The panel is a real-time read of what the skeleton is doing across the last several weeks. DXA is a lagged read of what the skeleton did across the last two years.

The Draw-Protocol Discipline

The reason bone-turnover markers are underused in sports-nutrition workflows is that a sloppy draw produces uninterpretable numbers. The protocol I hold on every draw:

Morning draw between 07:30 and 09:30 in a fasted state (nothing but water since 22:00 the prior evening). Coffee counts as food for this purpose because it acutely suppresses CTX through its indirect meal-state signaling. This eliminates the diurnal peak overshoot and the meal-state suppression that together can shift CTX by 40 percent or more on a random-time draw.

No hard training in the 24 hours preceding the draw. Acute high-intensity mechanical loading transiently elevates P1NP and shifts CTX in a partially decoupled pattern for approximately 24 to 48 hours post-session. Draw the panel on a rest day or an easy-recovery day. The training log has to be checked at the intake to schedule the draw correctly.

No pharmacologic or nutraceutical suppressors of resorption in the two weeks preceding the draw where the athlete has independent control over them. Bisphosphonates, denosumab, teriparatide, and estrogen (in the setting of oral contraceptive use) all move the markers substantially. Athletes on any of these are a separate interpretive picture. Common OTC agents to check at intake: high-dose vitamin K2 supplementation, high-dose calcium supplementation with vitamin D, and any "bone support" formulas the athlete has picked up on their own without documenting the ingredients.

Same lab and same assay across the reassessment cadence. Between-assay variability on both markers is meaningful (roughly 10 to 20 percent), and comparing a Quest Roche β-CrossLaps to a LabCorp CTX Elecsys is not a valid within-athlete trajectory. Pick the lab and assay at the first draw and hold both across every subsequent draw across the reassessment cadence.

Without this protocol discipline the reference-range interpretation is not defensible. With it, the panel is highly reproducible and highly interpretable.

The Four Intake Signals That Should Trigger the Paired Panel

Any athlete with one or more prior stress reactions or stress fractures within the last 24 months, regardless of DXA read. DXA missed the presenting signal in the vignette above and it misses the presenting signal in most of the athletes I see with recurrent stress injuries. The paired panel opens the differential correctly at the intake regardless of what the DXA said.

Computed low energy availability at intake (below 30 kcal/kg FFM/day) sustained for six weeks or more. LEA drives net bone resorption before DXA registers the BMD loss. The paired turnover panel catches the signal at the intervention window that reverses cleanly. Waiting for DXA to change is waiting six to twelve months longer than the athlete's skeleton has.

Female athletes with menstrual dysfunction (secondary amenorrhea for three or more consecutive cycles, oligomenorrhea in a documented previously regular cycle) or male athletes with clinical or biochemical signs of low testosterone. The estrogen and testosterone signals are the two dominant hormonal drivers of bone-remodeling coupling in the athlete population, and hypogonadism in either sex uncouples the panel toward net resorption in a pattern the paired marker workup identifies.

Any athlete on prolonged carbohydrate restriction (ketogenic diet for more than 12 weeks, sustained low-carbohydrate high-fat training pattern) with performance stalling or musculoskeletal complaints. The bone-turnover-marker literature on prolonged carbohydrate restriction in the endurance-athlete population has shown a reproducible uncoupled net-resorption signal that reverses when adequate carbohydrate is restored, and the signal is worth checking rather than assuming the dietary pattern is bone-neutral because the athlete is otherwise well-fueled.

The Interpretation

Reference ranges vary by lab, assay, sex, and age. General adult premenopausal-female Roche β-CrossLaps reference commonly sits around 100 to 800 pg/mL fasted morning, with the median in the athletic-female population sitting toward the upper half of that range from the mechanical-loading stimulus. Adult-male CTX reference sits around 100 to 700 pg/mL. P1NP adult reference sits around 15 to 80 ng/mL for both sexes, again with the median in trained athletes sitting toward the upper half. The interpretation depends less on the absolute numbers against the population reference and more on the coupling ratio and the within-athlete trajectory across the reassessment cadence.

Coupled high-turnover pattern (healthy loaded skeleton). CTX and P1NP both elevated together, coupling ratio within the expected physiologic band. This is the pattern of a well-trained athlete with adequate energy availability and adequate hormonal signaling loading their skeleton effectively. It is not pathologic. It should not be over-read as "bone loss" or "osteoporosis risk" when the presenting picture is clean.

Coupled low-turnover pattern. Both markers suppressed together. Can indicate insufficient mechanical loading (detrained athlete, prolonged rest for injury), oversuppression from pharmacotherapy (bisphosphonate carryover), or a systemic signal (severe protein malnutrition, untreated hypothyroidism). Uncommon in the sports-nutrition intake base but worth naming when it appears.

Uncoupled net-resorption pattern (the LEA and hypogonadism signature). CTX elevated disproportionate to P1NP. Both may still be within their individual reference ranges, but the ratio has shifted toward resorption. This is the pattern the paired panel is designed to catch. It is the LEA-driven bone-loss signal, the estrogen-deficiency signal in the female-athlete triad or RED-S, the testosterone-deficiency signal in male hypogonadism, and the chronic-carbohydrate-restriction signal in some endurance patterns. Any of those drivers, alone or in combination.

Uncoupled net-formation pattern. P1NP elevated disproportionate to CTX. Consistent with a healthy anabolic response — recovery from a stress fracture during a well-programmed unloading-then-progressive-reloading window, resumption of loading after adequate energy-availability restoration, or the response to teriparatide therapy in the small subset of athletes prescribed it. Not typically a pathologic finding in the sports-nutrition workflow.

The SOAP Documentation

The assessment line names the coupling pattern explicitly so the referring physician or endocrinology consult starts at the correct question. My structure on the uncoupled net-resorption presentation reads: "Uncoupled net-resorption bone-turnover pattern documented on paired panel [date], with CTX at [value] pg/mL against the same-lab-same-assay reference upper of [value] and P1NP at [value] ng/mL against the reference upper of [value], producing a CTX-relative-to-P1NP ratio shifted toward net resorption inconsistent with the athlete's mechanical loading history and current training block. DXA [date] read within reference on the standard age-matched Z-score analysis but does not evaluate current bone-remodeling activity and does not rule out the active bone-loss signal the paired-marker panel evaluates. Working differential: [LEA-driven / hypogonadism-driven / carbohydrate-restriction-driven / combined] uncoupled net resorption consistent with the [presenting signal: recurrent stress injury / low computed energy availability / menstrual dysfunction / chronic carbohydrate restriction]. Intervention plan documented below. Reassessment cadence: paired-marker redraw at 12 to 16 weeks using the identical draw protocol and identical lab and assay, DXA repeat at 12 months, coordinated with the referring physician on the specific hormonal and mechanical-loading workup."

The plan documents four elements. First, an energy-availability intervention that restores intake to at least 40 kcal/kg FFM/day for the reassessment window with the specific carbohydrate, protein, and calcium targets that get the athlete there, tracked daily against a paired food-log-and-training-log dashboard rather than a single-visit recall. Second, a paired mechanical-loading conversation with the coach that ensures the current training block includes bone-loading stimulus appropriate to the athlete's sport (impact work for endurance athletes whose primary training modality is non-impact, progressive plyometric loading for athletes deconditioned from injury unload). Third, a hormonal workup coordinated with the referring physician (paired estradiol and LH in female athletes with menstrual dysfunction, paired total-and-free testosterone plus LH-and-FSH in male athletes with clinical hypogonadism signals, prolactin and thyroid where the differential opens further). Fourth, the reassessment schedule with paired-marker redraw at 12 to 16 weeks and DXA repeat at 12 months, with an interim 4-week symptom-and-training-response check that catches the intervention-response signal before the panel redraws.

The Reassessment Loop

At the 12-to-16-week paired-marker redraw, three outcomes:

Coupling ratio normalized with symptomatic improvement and no new stress injury during the reassessment window. The intervention landed. Continue the intervention through the training block, hold the next paired-marker draw at the end of the current macrocycle as a monitoring tool, and use the paired panel proactively at annual pre-season checkpoints for the recurrent-stress-injury population going forward.

Coupling ratio partially normalized, symptoms partially improved. Intensify the intervention. Reassess the energy-availability computation with a refreshed 14-day food log paired against the current training log, revisit the mechanical-loading conversation with the coach, coordinate with the referring physician on the hormonal workup if not already opened. Extend the reassessment window by another 12 to 16 weeks and redraw again.

Coupling ratio unchanged or worsened. The differential has to expand. Referral to sports-medicine or endocrinology for the expanded workup if not already opened. Consider adjunct pharmacotherapy in the small subset where LEA correction and mechanical-loading correction alone are insufficient — this is a physician-driven decision the sports RD supports rather than owns, and the paired-marker panel is the empirical foundation the physician needs to have that conversation with the athlete.

Why the Paired Panel Should Be Standard on the Recurrent-Stress-Injury and RED-S Workflow

The paired CTX-and-P1NP panel is inexpensive when ordered as a pair through the referring physician (frequently $60 to $120 direct-to-consumer, sometimes covered by insurance with the appropriate stress-injury or LEA differential documented at order). It is fast to draw. It is highly interpretable when the draw protocol is held. It reads a signal DXA cannot see and it opens the intervention window at the point the intervention still reverses cleanly. Moving it from a tertiary-endocrinology tool into the sports-RD-driven intake protocol for the appropriate presentations — recurrent stress injury, sustained LEA, menstrual dysfunction, prolonged carbohydrate restriction with musculoskeletal complaint — is one of the highest-leverage changes I have made to my workup in the last three years, and the response I get from referring physicians when the paired panel arrives on the follow-up letter alongside a coherent coupling read is a different conversation from the one that starts at "the DXA is fine."

Where Calsanova Fits

The paired bone-turnover-marker workup depends on the intake carrying the draw-protocol discipline (fasted morning, no hard training in preceding 24 hours, same lab and assay across the reassessment cadence), the paired-marker entry with the coupling-ratio computation done at data entry rather than left to manual arithmetic at interpretation, the DXA-plus-turnover-marker composite view that surfaces the discrepancy between the two, and the reassessment schedule tracked automatically against the intervention start date. Calsanova's clinical intake carries the paired CTX-and-P1NP entry with automatic coupling-ratio computation and the athlete-population interpretive flags distinct from the standard reference-range flags, the draw-protocol prompt at panel-order time that documents the fasted-morning-no-recent-training requirement and the same-lab-same-assay hold, the paired DXA-plus-turnover-marker composite view that surfaces the DXA-clear-with-turnover-uncoupled pattern the vignette above opened with, and the reassessment schedule that pre-populates the 12-to-16-week paired-marker redraw plus the 12-month DXA repeat against the intervention start date with the interim 4-week symptom-and-training-response check.

Ready to move your sports-nutrition intake workflow into a purpose-built clinical system? Try Calsanova free for 30 days — no credit card, HIPAA-ready from day one, and the paired bone-turnover-marker workup runs automatically on every lab entry with the coupling ratio computed and the reassessment schedule pre-populated against the intervention start date.